BP-lowering treatment for patients with type 2 diabetes associated with improved mortality
the ONA take:
According to a new study published in JAMA, researchers have found that blood pressure-lowering treatment in patients with type 2 diabetes is associated with a decreased risk of cardiovascular disease and cardiovascular disease events, coronary heart disease events, and mortality.
For the meta-analysis, researchers identified 40 randomized controlled trials of blood pressure-lowering therapy conducted between 1966 and 2014 that included over 100,000 participants in order to investigate the associations between blood pressure-lowering treatment and cardiovascular disease in patients with type 2 diabetes.
Researchers found that each 10mm Hg lowering of systolic blood pressure was linked with a lower risk of cardiovascular disease events, coronary heart disease events, mortality, stroke, retinopathy, and albuminuria. Researchers did not find a significant difference in associations between blood-pressure lowering treatments and outcomes except for heart failure and stroke.
Results showed that blood pressure reduction below 130mm Hg was associated with a decreased risk of albuminuria, retinopathy, and stroke, but most outcomes had a decreased risk when systolic blood pressure was below 140mm Hg.
The findings supports current guideline recommendations that patients with type 2 diabetes be treated with antihypertensive therapy when their systolic blood pressure is above 140mm Hg.
Blood pressure-lowering treatment in patients with type 2 diabetes is associated with a decreased risk of cardiovascular disease.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- MRD Negativity Associated With Prolonged Survival in Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|